Clinical Trials Browser

Phase 2 × Leukoplakia, Oral × Nivolumab × Clear all

NCT03692325 2024-10-01

Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia

Phase 2 Completed

33 enrolled 15 charts

Leukoplakia, Oral